Publicaciones en colaboración con investigadores/as de Uppsala University (14)

2020

  1. Pharmacokinetics of antiretroviral and tuberculosis drugs in children with HIV/TB co-infection: A systematic review

    Journal of Antimicrobial Chemotherapy, Vol. 75, Núm. 12, pp. 3433-3457

2017

  1. Clinical characterization of patients with autosomal dominant short stature due to aggrecan mutations

    Journal of Clinical Endocrinology and Metabolism, Vol. 102, Núm. 2, pp. 460-469

2016

  1. Prescribing patterns of combined hormonal products containing cyproterone acetate, levonorgestrel and drospirenone in the UK

    JOURNAL OF FAMILY PLANNING AND REPRODUCTIVE HEALTH CARE, Vol. 42, Núm. 4, pp. 247-254

2015

  1. The continuation rates of long-acting reversible contraceptives in UK general practice using data from The Health Improvement Network

    Pharmacoepidemiology and Drug Safety, Vol. 24, Núm. 1, pp. 52-58

2014

  1. Study of long-acting reversible contraceptive use in a UK primary care database: Validation of methodology

    European Journal of Contraception and Reproductive Health Care, Vol. 19, Núm. 1, pp. 22-28

  2. Use of long-acting reversible contraceptives in the UK from 2004 to 2010: Analysis using the health improvement network database

    European Journal of Contraception and Reproductive Health Care, Vol. 19, Núm. 6, pp. 439-447

  3. Use of prescription contraceptive methods in the UK general population: A primary care study

    BJOG: An International Journal of Obstetrics and Gynaecology, Vol. 121, Núm. 1, pp. 53-61

2012

  1. Epidemiology of meningioma in the United Kingdom

    Neuroepidemiology, Vol. 39, Núm. 1, pp. 27-34

  2. Hormonal therapies and meningioma: Is there a link?

    Cancer Epidemiology, Vol. 36, Núm. 2, pp. 198-205

  3. International differences in self-reported health measures in 33 major metropolitan areas in Europe

    European Journal of Public Health, Vol. 22, Núm. 1, pp. 40-47

2008

  1. Risk of myocardial infarction and overall mortality in survivors of venous thromboembolism

    Thrombosis Journal, Vol. 6

2007

  1. Risk factors and short-term mortality of venous thromboembolism diagnosed in the primary care setting in the United Kingdom

    ARCHIVES OF INTERNAL MEDICINE, Vol. 167, Núm. 9, pp. 935-943

2003

  1. Users of oral steroids are at a reduced risk of developing irritable bowel syndrome

    Pharmacoepidemiology and Drug Safety, Vol. 12, Núm. 7, pp. 583-588

2002

  1. Risk of irritable bowel syndrome among asthma patients

    Pharmacoepidemiology and Drug Safety, Vol. 11, Núm. 1, pp. 31-35